BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28694201)

  • 41. Diagnostic performance of whole-blood interferon-γ assay and enzyme-linked immunospot assay for active tuberculosis'.
    Lai CC; Tan CK; Lin SH; Liao CH; Huang YT; Hsueh PR
    Diagn Microbiol Infect Dis; 2011 Oct; 71(2):139-43. PubMed ID: 21840675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers.
    Joshi M; Monson TP; Joshi A; Woods GL
    Ann Am Thorac Soc; 2014 Mar; 11(3):296-302. PubMed ID: 24446969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disseminated nontuberculous mycobacterial infection with cryptic immunodeficiency mimicking malignancy: a case report.
    Sun X; Zhang T; Sun H; Sun X
    BMC Pulm Med; 2022 Nov; 22(1):452. PubMed ID: 36447235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depressed Gamma Interferon Responses and Treatment Outcomes in Tuberculosis Patients: a Prospective Cohort Study.
    Feng JY; Pan SW; Huang SF; Chen YY; Lin YY; Su WJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors influencing discordant results of the QuantiFERON-TB Gold In-tube test in patients with active TB.
    Jeon YL; Nam YS; You E; Yang JJ; Kim MJ; Cho SY; Park TS; Lee HJ
    J Infect; 2013 Oct; 67(4):288-93. PubMed ID: 23796867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-interferon-γ Antibody-seropositive Disseminated Nontuberculous Mycobacterial Infection Mimicking POEMS and TAFRO Syndromes.
    Hidekawa C; Yoshimi R; Kishimoto D; Kato H; Mitsuhashi M; Sakurai N; Sato Y; Uehara T; Iizuka Y; Komiya T; Hamada N; Nagai H; Soejima Y; Kamiyama R; Takase-Minegishi K; Kirino Y; Sakagami T; Nakajima H
    Intern Med; 2022 Aug; 61(15):2377-2385. PubMed ID: 35022342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
    Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
    PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
    Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
    Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Recurrent atypical mycobacterial infections in the adult: think of autoantibodies against interferon-gamma !].
    Picque JB; Blot M; Binois R; Jeudy G; Simonet AL; Cagnon J; Mahy S; Duong M; Buisson M; Chavanet P; Piroth L
    Rev Med Interne; 2012 Feb; 33(2):103-6. PubMed ID: 22236500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment.
    Sauzullo I; Mengoni F; Scrivo R; Valesini G; Potenza C; Skroza N; Marocco R; Lichtner M; Vullo V; Mastroianni CM
    Int J Tuberc Lung Dis; 2010 Jul; 14(7):834-40. PubMed ID: 20550765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
    PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.
    Yang C; Luo X; Fan L; Sha W; Xiao H; Cui H
    Front Cell Infect Microbiol; 2020; 10():571230. PubMed ID: 33680977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An interferon-gamma release assay for the diagnosis of the Mycobacterium bovis infection in white rhinoceros (Ceratotherium simum).
    Chileshe J; Roos EO; Goosen WJ; Buss P; Hausler G; Rossouw L; Manemela T; van Helden P; Warren R; Parsons SD; Miller M
    Vet Immunol Immunopathol; 2019 Nov; 217():109931. PubMed ID: 31522092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis.
    Chang PC; Wang PH; Chen KT
    Int J Environ Res Public Health; 2017 Feb; 14(3):. PubMed ID: 28264462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triple infection with Cryptococcus, varicella-zoster virus, and Mycobacterium abscessus in a patient with anti-interferon-gamma autoantibodies: a case report.
    Rujirachun P; Sangwongwanich J; Chayakulkeeree M
    BMC Infect Dis; 2020 Mar; 20(1):232. PubMed ID: 32188404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics of IFN-γ responses in IGRA among pulmonary TB suspects in a TB-endemic area.
    Feng JY; Huang SF; Lee MC; Ting WY; Chen YC; Lin YY; Lee YC; Su WJ
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):46-52. PubMed ID: 23867329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Palmieri F; Cirillo DM; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dynamic changes in positive interferon-gamma release assay in a dialysis population: An observational cohort study.
    Shu CC; Wu VC; Yang FJ; Hsu CL; Pan SC; Wang JY; Wang JT; Yu CJ; Lee LN
    J Infect; 2013 Dec; 67(6):529-35. PubMed ID: 23933475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [DISSEMINATED NONTUBERCULOUS MYCOBACTERIOSIS THAT IS POSITIVE FOR NEUTRALIZING ANTI-INTERFERON-GAMMA AUTOANTIBODIES: A NEW DISEASE CONCEPT BASED ON HOST FACTORS].
    Sakagami T
    Kekkaku; 2015 Jun; 90(6):561-4. PubMed ID: 26489159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.